Evidence map›Paper›PMID 26569295›Full record

ArticleNutrients2015

Pomegranate Peel Extract Prevents Bone Loss in a Preclinical Model of Osteoporosis and Stimulates Osteoblastic Differentiation in Vitro.

Mélanie Spilmont, Laurent Léotoing, Marie-Jeanne Davicco, Patrice Lebecque, Elisabeth Miot-Noirault, Paul Pilet, Laurent Rios, Yohann Wittrant, Véronique Coxam

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Viruses · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Fruits By-Products - A Source of Valuable Active Principles. A Short Review.Frontiers in bioengineering and biotechnology · 2020
    Review
  17. Article
  18. Molecular targets of pomegranate (Iranian journal of basic medical sciences · 2019
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Mélanie SpilmontUnité de Nutrition Humaine, CRNH Auvergne, UMR 1019, INRA, F-63000 Clermont-Ferrand, France. mel.spilmont@gmail.com.
Laurent LéotoingUnité de Nutrition Humaine, CRNH Auvergne, UMR 1019, INRA, F-63000 Clermont-Ferrand, France. laurent.leotoing@clermont.inra.fr.
Marie-Jeanne DaviccoUnité de Nutrition Humaine, CRNH Auvergne, UMR 1019, INRA, F-63000 Clermont-Ferrand, France. marie-jeanne.davicco@clermont.inra.fr.
Patrice LebecqueUnité de Nutrition Humaine, CRNH Auvergne, UMR 1019, INRA, F-63000 Clermont-Ferrand, France. Patrice.Lebecque@clermont.inra.fr.
Elisabeth Miot-NoiraultImagerie Moléculaire et Thérapie Vectorisée, Université d'Auvergne, Clermont Université, UMR 990, INSERM, BP 10448, F-63000 Clermont-Ferrand, France. elisabeth.noirault@inserm.fr.
Paul PiletLaboratoire d'Ingénierie Ostéo-Articulaire et Dentaire-LIOAD, Université de Nantes, UMR 791, INSERM, F-44042 Nantes, France. paul.pilet@univ-nantes.fr.
Laurent RiosGREENTECH SA Biopôle Clermont-Limagne, F-63360 Saint-Beauzire, France. laurent.rios@vetagro-sup.fr.
Yohann WittrantUnité de Nutrition Humaine, CRNH Auvergne, UMR 1019, INRA, F-63000 Clermont-Ferrand, France. yohann.wittrant@clermont.inra.fr.
Véronique CoxamUnité de Nutrition Humaine, CRNH Auvergne, UMR 1019, INRA, F-63000 Clermont-Ferrand, France. veronique.coxam@clermont.inra.fr.
Centre de Recherche en Nutrition Humaine d'Auvergne · FRInserm · FRUniversité Clermont Auvergne · FRGroupe de Recherche en Énergie Électrique de Nancy · FRUnité de Nutrition Humaine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nutritional benefits of pomegranate have attracted great scientific interest. The pomegranate, including the pomegranate peel, has been used worldwide for many years as a fruit with medicinal activity, mostly antioxidant properties. Among chronic diseases, osteoporosis, which is associated with bone remodelling impairment leading to progressive bone loss, could eventually benefit from antioxidant compounds because of the involvement of oxidative stress in the pathogenesis of osteopenia. In this study, with in vivo and ex vivo experiments, we investigated whether the consumption of pomegranate peel extract (PGPE) could limit the process of osteopenia. We demonstrated that in ovariectomized (OVX) C57BL/6J mice, PGPE consumption was able to significantly prevent the decrease in bone mineral density (-31.9%; p < 0.001 vs. OVX mice) and bone microarchitecture impairment. Moreover, the exposure of RAW264.7 cells to serum harvested from mice that had been given a PGPE-enriched diet elicited reduced osteoclast differentiation and bone resorption, as shown by the inhibition of the major osteoclast markers. In addition, PGPE appeared to substantially stimulate osteoblastic MC3T3-E1 alkaline phosphatase (ALP) activity at day 7, mineralization at day 21 and the transcription level of osteogenic markers. PGPE may be effective in preventing the bone loss associated with ovariectomy in mice, and offers a promising alternative for the nutritional management of this disease.

Indexed as

3T3 CellsAlkaline PhosphataseAnimalsAntioxidantsBone and BonesBone DensityCell DifferentiationDisease Models, AnimalDrug Evaluation, PreclinicalFemaleFruitLythraceaeMiceMice, Inbred C57BLOsteoblastsOsteoporosisAlkaline PhosphataseAntioxidantsPlant Extractsanimal modelbone healthcell linesnutritional preventionpomegranate peel extract

Identifiers

PMID26569295
PMCPMC4663593
OpenAlexW2127804038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.